abstract |
Therapies using a combination of antiviral agents and EP4 receptor agonists for the treatment of human respiratory diseases associated with viral infections are described. Viral infections may include influenza A viruses such as H1N1, H3N2 and H5N1, and mutations thereof, and / or coronaviruses, such as severe acute respiratory syndrome, viruses that cause "SARS". |